• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 14187 Citations
  • 42 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1986 2019

Filter
Review article
2018
19 Citations (Scopus)

Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions

Vijayaraghavan, S., Moulder, S., Keyomarsi, K. & Layman, R. M., Feb 1 2018, In : Targeted oncology. 13, 1, p. 21-38 18 p.

Research output: Contribution to journalReview article

Cyclin-Dependent Kinases
Neoplasms
Breast Neoplasms
Cell Cycle
Therapeutics
6 Citations (Scopus)

Low-molecular-weight cyclin E in human cancer: Cellular consequences and opportunities for targeted therapies

Caruso, J. A., Duong, M. T., Carey, J. P. W., Hunt, K. K. & Keyomarsi, K., Oct 1 2018, In : Cancer research. 78, 19, p. 5481-5491 11 p.

Research output: Contribution to journalReview article

Cyclin E
Molecular Weight
Neoplasms
Cyclin-Dependent Kinase 2
Therapeutics
2 Citations (Scopus)

Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy

Fu, S., Wang, Y., Keyomarsi, K. & Meric-Bernstein, F., Sep 2 2018, In : Expert Opinion on Investigational Drugs. 27, 9, p. 741-751 11 p.

Research output: Contribution to journalReview article

Phosphotransferases
Neoplasms
Therapeutics
Biomarkers
Expert Testimony
2015
3 Citations (Scopus)

How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?

Pickering, C. R., Bast, R. C. & Keyomarsi, K., Mar 1 2015, In : Cancer. 121, 6, p. 806-816 11 p.

Research output: Contribution to journalReview article

Translational Medical Research
Research Personnel
Physicians
Physician's Role
Clinical Medicine
2005
43 Citations (Scopus)

Cyclin E as a prognostic and predictive marker in breast cancer

Hunt, K. K. & Keyomarsi, K., Aug 1 2005, In : Seminars in cancer biology. 15, 4, p. 319-326 8 p.

Research output: Contribution to journalReview article

Cyclin E
Breast Neoplasms
Therapeutics
Patient Selection
Neoplasms
2003
68 Citations (Scopus)

Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.

Akli, S. & Keyomarsi, K., Jan 1 2003, In : Cancer biology & therapy. 2, 4 Suppl 1

Research output: Contribution to journalReview article

Cyclin E
Molecular Weight
Neoplasms
Cyclin-Dependent Kinases
S Phase
26 Citations (Scopus)

Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents.

Keyomarsi, K. & Pardee, A. B., 2003, In : Progress in cell cycle research. 5, p. 527-532 6 p.

Research output: Contribution to journalReview article

Poisons
Neoplasms
Cytoprotection
Drug Discovery
Cell Differentiation
1997
108 Citations (Scopus)

The role of cyclin E in cell proliferation, development and cancer.

Keyomarsi, K. & Herliczek, T. W., Jan 1 1997, In : Progress in cell cycle research. 3, p. 171-191 21 p.

Research output: Contribution to journalReview article

Cyclin E
Cell Proliferation
G1 Phase Cell Cycle Checkpoints
Neoplasms
Cyclins